Illumine Investment Management LLC Takes $280,000 Position in Simulations Plus, Inc. (NASDAQ:SLP)

Illumine Investment Management LLC acquired a new stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 10,055 shares of the technology company’s stock, valued at approximately $280,000. Illumine Investment Management LLC owned about 0.05% of Simulations Plus as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Proficio Capital Partners LLC acquired a new stake in Simulations Plus in the 4th quarter worth about $719,000. Olympiad Research LP acquired a new position in Simulations Plus during the fourth quarter worth approximately $211,000. Rice Hall James & Associates LLC raised its stake in Simulations Plus by 19.4% during the fourth quarter. Rice Hall James & Associates LLC now owns 91,500 shares of the technology company’s stock worth $2,552,000 after purchasing an additional 14,871 shares during the period. Principal Financial Group Inc. grew its stake in shares of Simulations Plus by 4.5% during the 4th quarter. Principal Financial Group Inc. now owns 91,177 shares of the technology company’s stock valued at $2,543,000 after buying an additional 3,904 shares during the period. Finally, Stephens Inc. AR purchased a new stake in shares of Simulations Plus during the 4th quarter valued at $905,000. 78.08% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $33.91, for a total value of $678,200.00. Following the completion of the transaction, the director now owns 3,402,584 shares in the company, valued at approximately $115,381,623.44. This represents a 0.58 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 19.40% of the company’s stock.

Analyst Ratings Changes

SLP has been the topic of several research analyst reports. KeyCorp lifted their price objective on Simulations Plus from $35.00 to $37.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Stephens began coverage on shares of Simulations Plus in a research report on Friday, November 15th. They issued an “overweight” rating and a $39.00 price objective for the company. William Blair restated an “outperform” rating on shares of Simulations Plus in a report on Wednesday, January 8th. Finally, StockNews.com cut shares of Simulations Plus from a “hold” rating to a “sell” rating in a research report on Monday, November 4th. One research analyst has rated the stock with a sell rating, one has given a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Simulations Plus presently has a consensus rating of “Moderate Buy” and a consensus price target of $49.40.

Simulations Plus Stock Down 3.9 %

NASDAQ:SLP opened at $29.21 on Friday. Simulations Plus, Inc. has a 52 week low of $24.00 and a 52 week high of $51.22. The company has a market cap of $586.89 million, a PE ratio of 73.03 and a beta of 0.83. The business’s 50 day moving average is $31.76 and its two-hundred day moving average is $31.97.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.